Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Amonafide L-malate

EU orphan designation number: EU/3/07/483
Active ingredient: Amonafide L-malate
Indication: Treatment of acute myeloid leukaemia
Sponsor: Antisoma Research Ltd
Chiswick Park Building 5, 566 Chiswick High Road, London W4 5YF, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/10/2007 Orphan designation EMEA/OD/069/07 (2007)5244 of 22/10/2007
09/01/2009 Transfer of orphan designation EMEA/OD/069/07/T/01 (2009)16 of 05/01/2009
11/03/2011 Removal of orphan designation from Community Register